Drugs / ASA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03629327 Comparator | Jan 2022 → Sep 2024 | HIV infectious disease | University of Manitoba | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03629327 ↗ |
| Route | Oral | “Participants will be randomized to take 81mg orally on a daily basis for a duration of 6 months” NCT03629327 ↗ |